Delivery Order SPE2DR25D1102-SPE2DR26FFA7M
Award Date 12/5/25
Potential Completion Date 12/8/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,635.36 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML Vial, a hepatitis B vaccine product. The contract, awarded on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of ENGERIX-B 20 MCG/ML (a hepatitis B vaccine) with a ceiling value of $1,422.15. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's extensive pharmaceutical distribution...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on December 15, 2025, for ENGERIX-B 20 micrograms per milliliter syringes, valued at $17,604.49. This competitively awarded, firm fixed-price delivery order is set to conclude by December 16, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.36 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML Vial, a hepatitis B vaccine product. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor specializing...
- The Defense Logistics Agency awarded a $1,080.34 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with performance at the company's Conshohocken, Pennsylvania location. This non-competitive, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfilled this order under its existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.76 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 mcg/mL vials on December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award of the pharmaceutical product. The contract is set to be completed by December 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a...
- The Defense Logistics Agency awarded a $2,346.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply on December 8, 2025, with completion scheduled for December 9, 2025. The contract was awarded competitively without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $11,147.44 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML vaccine product. This firm fixed-price, competitively awarded contract was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML vaccine on June 3, 2025, with a ceiling value of $3,753.42. This is a firm fixed price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award is issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for ENGERIX-B 20 MCG/ML vaccine supply, with a ceiling value of $2,567.38. This firm fixed-price delivery order, with an ultimate completion date of April 25, 2025, represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office...